Zheng Xing Xing Ye Ri Bao·2025-09-26 08:42Market Overview - On September 26, the biopharmaceutical sector declined by 0.95%, with Junshi Bioscience leading the drop [1] - The Shanghai Composite Index closed at 3828.11, down 0.65%, while the Shenzhen Component Index closed at 13209.0, down 1.76% [1] Stock Performance - Notable gainers in the biopharmaceutical sector included: - Aopumai (688293) with a closing price of 66.17, up 5.28% [1] - Kanghua Biological (300841) at 77.28, up 5.26% [1] - Changchun High-tech (000661) at 126.89, up 3.53% [1] - Significant decliners included: - Junshi Bioscience (688180) at 41.00, down 4.16% [2] - Olin Bio (688319) at 25.50, down 3.66% [2] - Baipusais (301080) at 59.90, down 3.64% [2] Capital Flow - The biopharmaceutical sector experienced a net outflow of 412 million yuan from institutional investors, while retail investors saw a net inflow of 205 million yuan [2] - The capital flow for specific stocks showed: - Aopumai had a net inflow of 26.26 million yuan from institutional investors [3] - Kanghua Biological had a net outflow of 1.11 million yuan from retail investors [3] - Tonghua Dongbao (600867) saw a net inflow of 15.15 million yuan from institutional investors [3]